|
|
Office Locations:
|
537 Steamboat Road, Suite 200
Greenwich, CT 06830
Phone: 203-769-2345
Fax: 201-402-1086
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Biomark Capital provides venture funding and assistance to early, mid, and late-stage life science companies. The firm targets companies with novel approaches to diagnostics, therapeutics, medical devices, and digital health that will change the face of healthcare innovation in the future. Biomark Capital's primary investment focus is in North America, along with a specific focus in Russia, Taiwan, India, and China. Initial investments typically range from $5-$10 million dollars. The team has over 50 years of combined investment experience.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
